Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
17 Mar 2020
Historique:
received: 19 06 2019
accepted: 28 02 2020
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 18 8 2020
Statut: epublish

Résumé

Several approaches to medication optimisation by identifying drug-related problems in older people have been described. Although some interventions have shown reductions in drug-related problems (DRPs), evidence supporting the effectiveness of medication reviews on clinical and economic outcomes is lacking. Application of the STOPP/START (version 2) explicit screening tool for inappropriate prescribing has decreased inappropriate prescribing and significantly reduced adverse drug reactions (ADRs) and associated healthcare costs in older patients with multi-morbidity and polypharmacy. Therefore, application of STOPP/START criteria during a medication review is likely to be beneficial. Incorporation of explicit screening tools into clinical decision support systems (CDSS) has gained traction as a means to improve both quality and efficiency in the rather time-consuming medication review process. Although CDSS can generate more potential inappropriate medication recommendations, some of these have been shown to be less clinically relevant, resulting in alert fatigue. Moreover, explicit tools such as STOPP/START do not cover all relevant DRPs on an individual patient level. The OPERAM study aims to assess the impact of a structured drug review on the quality of pharmacotherapy in older people with multi-morbidity and polypharmacy. The aim of this paper is to describe the structured, multi-component intervention of the OPERAM trial and compare it with the approach in the comparator arm. This paper describes a multi-component intervention, integrating interventions that have demonstrated effectiveness in defining DRPs. The intervention involves a structured history-taking of medication (SHiM), a medication review according to the systemic tool to reduce inappropriate prescribing (STRIP) method, assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2), followed by shared decision-making with both patient and attending physician. The developed method integrates patient input, patient data, involvement from other healthcare professionals and CDSS-assistance into one structured intervention. The clinical and economical effectiveness of this experimental intervention will be evaluated in a cohort of hospitalised, older patients with multi-morbidity and polypharmacy in the multicentre, randomized controlled OPERAM trial (OPtimising thERapy to prevent Avoidable hospital admissions in the Multi-morbid elderly), which will be completed in the last quarter of 2019. Universal Trial Number: U1111-1181-9400 Clinicaltrials.gov: NCT02986425, Registered 08 December 2016. FOPH (Swiss national portal): SNCTP000002183. Netherlands Trial Register: NTR6012 (07-10-2016).

Sections du résumé

BACKGROUND BACKGROUND
Several approaches to medication optimisation by identifying drug-related problems in older people have been described. Although some interventions have shown reductions in drug-related problems (DRPs), evidence supporting the effectiveness of medication reviews on clinical and economic outcomes is lacking. Application of the STOPP/START (version 2) explicit screening tool for inappropriate prescribing has decreased inappropriate prescribing and significantly reduced adverse drug reactions (ADRs) and associated healthcare costs in older patients with multi-morbidity and polypharmacy. Therefore, application of STOPP/START criteria during a medication review is likely to be beneficial. Incorporation of explicit screening tools into clinical decision support systems (CDSS) has gained traction as a means to improve both quality and efficiency in the rather time-consuming medication review process. Although CDSS can generate more potential inappropriate medication recommendations, some of these have been shown to be less clinically relevant, resulting in alert fatigue. Moreover, explicit tools such as STOPP/START do not cover all relevant DRPs on an individual patient level. The OPERAM study aims to assess the impact of a structured drug review on the quality of pharmacotherapy in older people with multi-morbidity and polypharmacy. The aim of this paper is to describe the structured, multi-component intervention of the OPERAM trial and compare it with the approach in the comparator arm.
METHOD METHODS
This paper describes a multi-component intervention, integrating interventions that have demonstrated effectiveness in defining DRPs. The intervention involves a structured history-taking of medication (SHiM), a medication review according to the systemic tool to reduce inappropriate prescribing (STRIP) method, assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2), followed by shared decision-making with both patient and attending physician. The developed method integrates patient input, patient data, involvement from other healthcare professionals and CDSS-assistance into one structured intervention.
DISCUSSION CONCLUSIONS
The clinical and economical effectiveness of this experimental intervention will be evaluated in a cohort of hospitalised, older patients with multi-morbidity and polypharmacy in the multicentre, randomized controlled OPERAM trial (OPtimising thERapy to prevent Avoidable hospital admissions in the Multi-morbid elderly), which will be completed in the last quarter of 2019.
TRIAL REGISTRATION BACKGROUND
Universal Trial Number: U1111-1181-9400 Clinicaltrials.gov: NCT02986425, Registered 08 December 2016. FOPH (Swiss national portal): SNCTP000002183. Netherlands Trial Register: NTR6012 (07-10-2016).

Identifiants

pubmed: 32183810
doi: 10.1186/s12913-020-5056-3
pii: 10.1186/s12913-020-5056-3
pmc: PMC7076919
doi:

Banques de données

ClinicalTrials.gov
['NCT02986425']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

220

Subventions

Organisme : Staatssekretariat für Bildung, Forschung und Innovation
ID : 15.0137
Organisme : Horizon 2020
ID : 634238

Références

Chest. 2010 Nov;138(5):1093-100
pubmed: 20299623
Eur J Clin Pharmacol. 2015 Oct;71(10):1255-62
pubmed: 26249851
Clin Pharmacol Ther. 2011 Jun;89(6):845-54
pubmed: 21508941
Med J Aust. 1998 Jul 20;169(2):85-8
pubmed: 9700343
Am J Geriatr Pharmacother. 2010 Apr;8(2):115-26
pubmed: 20439061
Ned Tijdschr Geneeskd. 2010;154:A904
pubmed: 20356426
BMJ. 2004 Jul 3;329(7456):15-9
pubmed: 15231615
Drugs Aging. 2016 Jan;33(1):63-73
pubmed: 26597401
Int J Clin Pharm. 2016 Apr;38(2):374-9
pubmed: 26797770
BMJ. 2010 Oct 14;341:c5146
pubmed: 20947577
Arch Intern Med. 2008 Sep 22;168(17):1890-6
pubmed: 18809816
Cochrane Database Syst Rev. 2014 Oct 07;(10):CD008165
pubmed: 25288041
Value Health. 2011 Jan;14(1):34-40
pubmed: 21211484
Drug Saf. 2012 Jan;35 Suppl 1:47-54
pubmed: 23446785
Clin Interv Aging. 2016 Jun 23;11:857-66
pubmed: 27382268
Expert Opin Drug Saf. 2014 Jan;13(1):57-65
pubmed: 24073682
Pharmacoepidemiol Drug Saf. 2003 Sep;12(6):491-8
pubmed: 14513663
J Am Geriatr Soc. 2019 Sep;67(9):1843-1850
pubmed: 31250427
Drugs Aging. 2015 Jun;32(6):495-503
pubmed: 26025118
PLoS One. 2018 Apr 18;13(4):e0195232
pubmed: 29668763
Age Ageing. 2015 Mar;44(2):213-8
pubmed: 25324330
Nephrol Dial Transplant. 2011 Oct;26(10):3176-81
pubmed: 21325352
Drugs Aging. 2009;26(8):687-701
pubmed: 19685934
Br J Clin Pharmacol. 2009 Jun;67(6):671-5
pubmed: 19594536
BMC Med. 2018 Feb 13;16(1):21
pubmed: 29433501
J Gen Intern Med. 2012 Oct;27(10):1361-7
pubmed: 22618581
J Am Geriatr Soc. 2016 Aug;64(8):1558-66
pubmed: 27365262
J Am Geriatr Soc. 2011 Oct;59(10):1976-7
pubmed: 22091519
Br J Clin Pharmacol. 2014 Oct;78(4):738-47
pubmed: 24661192
J Clin Epidemiol. 2001 Jul;54(7):680-6
pubmed: 11438408
CMAJ. 2005 Aug 30;173(5):510-5
pubmed: 16129874
BMC Geriatr. 2017 Oct 10;17(1):230
pubmed: 29017448
J Am Acad Nurse Pract. 2005 Apr;17(4):123-32
pubmed: 15819637
JAMA Intern Med. 2015 May;175(5):827-34
pubmed: 25798731
CNS Drugs. 2013 Nov;27(11):963-9
pubmed: 23959814
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
Age Ageing. 2018 Sep 1;47(5):670-678
pubmed: 29893779
J Eval Clin Pract. 2018 Apr;24(2):317-322
pubmed: 28776873
Emerg Med J. 2014 Jan;31(1):24-9
pubmed: 23389832
J Clin Pharm Ther. 2018 Apr;43(2):224-231
pubmed: 28971492
BMJ Open. 2019 Jun 3;9(6):e026769
pubmed: 31164366

Auteurs

Erin K Crowley (EK)

Pharmaceutical Care Research Group. School of Pharmacy, Cavanagh Pharmacy Building, University College Cork, Cork, Ireland.

Bastiaan T G M Sallevelt (BTGM)

Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Corlina J A Huibers (CJA)

Department of Geriatric Medicine and Expertise Centre Pharmacotherapy in Old Persons, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Kevin D Murphy (KD)

Pharmaceutical Care Research Group. School of Pharmacy, Cavanagh Pharmacy Building, University College Cork, Cork, Ireland. kevin.murphy@ucc.ie.

Marco Spruit (M)

Department of Information and Computing Sciences, Utrecht University, Princetonplein 5, 3584CC, Utrecht, The Netherlands.

Zhengru Shen (Z)

Department of Information and Computing Sciences, Utrecht University, Princetonplein 5, 3584CC, Utrecht, The Netherlands.

Benoît Boland (B)

Department of Geriatric Medicine, Cliniques universitaires Saint-Luc, Université catholique de Louvain UCLouvain, Brussels, Belgium.
Institute of Health and Society, Université catholique de Louvain UCLouvain, Brussels, Belgium.

Anne Spinewine (A)

Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain UCLouvain, Brussels, Belgium.
Pharmacy Department, CHU Dinant-Godinne UCL Namur, Université catholique de Louvain UCLouvain, Yvoir, Belgium.

Olivia Dalleur (O)

Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain UCLouvain, Brussels, Belgium.
Pharmacy Department, Cliniques universitaires Saint-Luc, Université catholique de Louvain UCLouvain, Brussels, Belgium.

Elisavet Moutzouri (E)

Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Axel Löwe (A)

Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Martin Feller (M)

Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Nathalie Schwab (N)

Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Luise Adam (L)

Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Ingeborg Wilting (I)

Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Wilma Knol (W)

Department of Geriatric Medicine and Expertise Centre Pharmacotherapy in Old Persons, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Nicolas Rodondi (N)

Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Stephen Byrne (S)

Pharmaceutical Care Research Group. School of Pharmacy, Cavanagh Pharmacy Building, University College Cork, Cork, Ireland.

Denis O'Mahony (D)

Department of Medicine, University College Cork, Cork, Ireland.
Department of Geriatric Medicine, Cork University Hospital, Cork, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH